What Your Testosterone Level Actually Tells You About Your Fertility
Part 3 of the SwimScore Hormone Series
Testosterone is the hormone men think they understand best. It's the one with the most cultural weight, the most direct-to-consumer testing, and the most aggressive treatment market built around it. It's also the one most commonly misunderstood when it comes to fertility specifically.
Here's the core issue: testosterone is essential for making sperm, but your blood testosterone level is not a reliable measure of whether you have enough of it where it matters. The testosterone driving spermatogenesis isn't in your bloodstream. It's concentrated inside your testes at levels 50 to 100 times higher than anything a blood test captures. And the most popular treatment for low testosterone, exogenous testosterone replacement, directly destroys that environment and is one of the most common preventable causes of male infertility.
This article is about what your testosterone result actually tells you, what it doesn't, and what it means for your fertility.
What Testosterone Does
Testosterone is produced primarily by Leydig cells in the testes, stimulated by LH from the pituitary gland. It serves two distinct functions relevant to fertility. First, it maintains the extraordinarily high local concentration inside the testes that spermatogenesis depends on. Second, it circulates systemically to support libido, muscle mass, bone density, mood, and the broader hormonal environment. These two functions are related but not the same thing, and they can become decoupled in ways that standard testosterone testing doesn't detect.
The testosterone concentration inside the testes is approximately 50 to 100 times higher than in the bloodstream. (PMC, 2022) Sperm development requires androgen signaling at concentrations that systemic circulation cannot sustain. The Sertoli cells that support developing sperm throughout spermatogenesis depend on local testosterone to produce the regulatory signals and nutrients that developing sperm need. When that local concentration falls, spermatogenesis is directly impaired, even if the circulating testosterone level on a blood test looks normal.
This is the first and most important thing to understand about testosterone and fertility: the number on your blood test is measuring the wrong pool.
Total Testosterone, Free Testosterone, and Why the Difference Matters
A standard testosterone blood test measures total testosterone, which includes all of the testosterone in circulation including the portion bound to proteins. Most circulating testosterone is bound to sex hormone-binding globulin, or SHBG, and albumin. Only a small fraction, roughly 2 to 3%, is unbound and biologically active. This free testosterone is what actually enters cells and exerts hormonal effects.
Two men can have identical total testosterone levels and very different free testosterone levels depending on their SHBG. High SHBG, which is associated with aging, liver conditions, and hyperthyroidism, reduces free testosterone even when total testosterone looks normal. Low SHBG, associated with obesity, insulin resistance, and hypothyroidism, can make total testosterone look lower than the functionally available amount actually is.
The clinical implication: a total testosterone result in isolation is incomplete. Free testosterone, calculated or directly measured, gives a more accurate picture of what is biologically active. The EAU guidelines and the American Urological Association both recommend measuring total and free testosterone together when evaluating hypogonadism. (EAU Guidelines on Sexual and Reproductive Health, 2024)
What the Normal Range Means
The reference range for total testosterone in adult men is generally 300 to 1,000 ng/dL, though this varies between labs and guidelines. The Endocrine Society defines hypogonadism as a total testosterone below 300 ng/dL alongside symptoms. The APHRODITE criteria, a clinical stratification framework developed by andrologists and reproductive specialists, uses 350 ng/dL as the threshold below which a man is classified as hypogonadal for fertility evaluation purposes. (PMC, 2024)
A normal testosterone alongside normal FSH, LH, and normal semen parameters is a reassuring combination. The hormonal chain is intact.
One important nuance: the relationship between serum testosterone and semen parameters is less direct than most men assume. A retrospective study of 853 men attending a fertility clinic found that men with low testosterone, defined as below 264 ng/dL, had lower average sperm parameters than men with normal testosterone, but the differences were not statistically significant. Low testosterone alone did not significantly predict poor semen parameters in that population. (PMC, 2020) A separate study of 214 idiopathic infertile men found that approximately 24% had testosterone below threshold, and that in this subgroup testosterone correlated with morphology, but the majority of infertile men in the study had testosterone within the normal range. (PMC, 2024)
What this means practically: low serum testosterone is an important finding that warrants investigation, but normal serum testosterone does not guarantee normal spermatogenesis, and mildly low testosterone does not always predict poor sperm quality. The full hormonal picture, testosterone alongside FSH and LH, is what generates meaningful clinical insight.
What Low Testosterone Means
Low testosterone, below roughly 300 ng/dL, is called hypogonadism. As covered in the FSH and LH articles, the pattern of associated FSH and LH tells you where in the system the problem sits.
Low testosterone with high FSH and high LH points to primary hypogonadism. The testes are being maximally signaled and still cannot produce adequate testosterone. The problem is testicular. This pattern is associated with Klinefelter syndrome, testicular damage from infection or injury, severe varicocele, and other conditions affecting testicular function directly.
Low testosterone with low or normal FSH and LH points to secondary hypogonadism. The pituitary signal is insufficient. The testes may be capable of producing testosterone if properly stimulated. This is the pattern most associated with modifiable causes: obesity, exogenous testosterone use, sleep apnea, chronic illness, and pituitary pathology.
Obesity deserves particular attention. Adipose tissue contains aromatase, the enzyme that converts testosterone to estradiol. The more body fat, particularly abdominal fat, the more of this conversion occurs. Higher estradiol suppresses the HPG axis through negative feedback, reducing LH, which reduces testicular stimulation, which reduces testosterone. Lower testosterone then impairs the regulatory environment for spermatogenesis and also tends to promote further fat deposition, creating a self-reinforcing cycle. A large cross-sectional study of 2,430 normospermic men over 14 years found that higher BMI correlated with declines in total sperm count, motility, volume, and morphology across all weight categories. (PMC, 2024) The pathway runs directly through testosterone suppression and increased oxidative stress driven by excess adipose tissue.
Low testosterone with poor semen parameters and a normal FSH is a pattern that warrants specific attention. It may reflect what some researchers describe as functional hypogonadism, where testosterone is sufficiently reduced to impair spermatogenesis without the FSH elevation that would accompany more severe primary testicular failure. In the study of 214 idiopathic infertile men, about a quarter of men met this profile: normal gonadotropins, altered semen parameters, and testosterone below threshold. The authors suggested this subgroup may respond differently to intervention than men with more clearly defined hormonal patterns. (PMC, 2024)
The TRT Problem
This needs to be said plainly, because it is one of the most consequential and underappreciated facts in male fertility: taking exogenous testosterone, whether prescribed for low T symptoms or used for performance, directly suppresses sperm production and can cause complete infertility.
Here is the mechanism. When external testosterone enters the bloodstream, the brain detects elevated circulating levels and suppresses the HPG axis through negative feedback. GnRH pulses from the hypothalamus decrease. LH and FSH from the pituitary drop. Leydig cells stop being stimulated. The intratesticular testosterone concentration, which must be 50 to 100 times the serum level to support spermatogenesis, collapses, even while the blood testosterone from the external source looks normal or high. FSH suppression simultaneously removes the Sertoli cell stimulation that supports developing sperm. Sperm production fails at both ends simultaneously. (PMC, 2022)
Studies of testosterone used as a male contraceptive found that sperm concentrations were suppressed to below 1 million per mL within an average of 3.5 months. (ScienceDirect, 2018) In a clinical survey context, approximately 15% of men presenting to fertility clinics with azoospermia or severe oligozoospermia are found to be on exogenous testosterone. Many were never told this was a risk.
Recovery after stopping TRT is possible in most men but not guaranteed, and takes longer than most expect. Studies of hormonal contraception indicate that most men have a return of normal sperm production within 12 months of stopping. (PMC, 2013) Recovery is slower with longer duration of use and older age. In one series, 69.7% of men who had been on TRT for a median of two years reached a total motile count above 5 million within 12 months of stopping, using hCG and clomiphene support. For men with longer duration of use or older age at discontinuation, recovery rates were lower. (MDPI, 2024)
For men who need testosterone therapy for genuine hypogonadism and also want to preserve fertility, alternatives exist. Human chorionic gonadotropin, or hCG, directly stimulates Leydig cells and maintains intratesticular testosterone during TRT. Low-dose hCG added to testosterone therapy has been shown in studies to preserve spermatogenesis and prevent azoospermia in most men. Clomiphene citrate and enclomiphene raise endogenous testosterone by stimulating the pituitary rather than replacing testosterone externally, meaning the HPG axis stays active and sperm production is preserved. These are prescription treatments requiring clinical management. But for any man of reproductive age being offered TRT, knowing these alternatives exist before starting is essential.
What High Testosterone Means
Elevated serum testosterone above the upper reference range is less commonly encountered in a fertility context but worth understanding.
The most common cause is exogenous testosterone use, which raises serum levels while simultaneously suppressing sperm production as described above. A very high serum testosterone result alongside suppressed FSH and LH is a strong indicator of exogenous use, even when not disclosed.
Beyond that, naturally elevated testosterone is rarely a direct fertility problem. Very high testosterone can increase aromatization to estradiol, which then suppresses the HPG axis as a secondary effect. True primary testosterone excess outside of exogenous sources is uncommon in men of reproductive age.
Reading Testosterone Alongside FSH and LH
The diagnostic patterns that matter are the combinations, not individual numbers.
High testosterone with suppressed FSH and LH: almost always exogenous testosterone or anabolic steroids. Sperm production is almost certainly severely impaired regardless of what the semen analysis shows.
Low testosterone with high FSH and high LH: primary testicular failure. Both testosterone production and spermatogenesis are impaired at the testicular level. The pituitary is compensating maximally and cannot overcome the problem.
Low testosterone with low or normal FSH and LH: secondary hypogonadism. The signal from the brain is insufficient. More likely to be modifiable through addressing obesity, sleep apnea, exogenous hormones, or pituitary pathology.
Normal testosterone with abnormal semen parameters: the hormonal axis appears intact but something is wrong downstream. Could reflect localized spermatogenic failure, oxidative stress, varicocele, or genetic factors affecting sperm development independently of hormonal signaling. DNA fragmentation is particularly relevant here, as it can be elevated even when all standard semen parameters and hormone levels look normal.
Normal testosterone with normal FSH, LH, and normal semen parameters: the hormonal picture is reassuring. If a couple is still experiencing difficulty conceiving, the investigation should shift toward timing, female factor fertility, and less commonly tested male parameters.
What Can Be Done
When low testosterone is driven by modifiable factors, the starting point is those factors rather than hormonal treatment.
Obesity is the most impactful modifiable cause. Weight loss, specifically fat loss, reduces peripheral aromatization, reduces estradiol-mediated HPG suppression, and allows testosterone to recover. Clinical data on bariatric surgery show testosterone increases superior to those achieved through lifestyle modification alone, though the evidence on sperm parameter improvement following weight loss remains mixed. (PMC, 2020)
Stopping exogenous testosterone is necessary when TRT is the cause. Recovery protocols using hCG alone or in combination with clomiphene or enclomiphene are the standard clinical approach, as described above.
Sleep apnea treatment through CPAP has been shown to improve testosterone levels in men with sleep-disordered breathing, through restoring the nocturnal testosterone surge that normal sleep enables.
When the cause of low testosterone is primary testicular failure, the options are more limited. Hormonal stimulation cannot overcome a testes that is not functioning. In these cases, the clinical conversation shifts toward assisted reproduction, sperm retrieval where applicable, and genetic evaluation.
Our Take
Testosterone is the hormone men already think they know about, which is exactly why it's so frequently mismanaged in the fertility context. The number on a blood test measures circulating testosterone, not the intratesticular concentration that actually drives sperm production. A normal result does not guarantee adequate spermatogenesis. A mildly low result does not always predict poor sperm quality. And the most widely used treatment for low testosterone, exogenous TRT, actively destroys the intratesticular environment that spermatogenesis requires.
We know that testosterone is essential for sperm production. We know that certain patterns, particularly low testosterone with high FSH and LH, or suppressed testosterone with suppressed gonadotropins, tell a clear diagnostic story. We know that modifiable causes, particularly obesity and exogenous testosterone use, are common and addressable. What is less clear is the threshold at which mildly low testosterone becomes clinically meaningful for fertility specifically, and how aggressively to treat borderline results in men without obvious cause.
The practical starting point is the same as throughout this series: know your numbers, read them in context, and understand what's driving them. Testosterone in isolation tells you less than testosterone alongside FSH, LH, and a semen analysis. That combination tells you whether the problem is in the signal, the testes, or somewhere else entirely. And that distinction determines everything about what to do next.
This is Part 3 of the SwimScore Hormone Series. Next up: Prolactin, the hormone most often overlooked in male fertility and one of the most treatable causes of hormonal disruption.
See here part 1 about LH and part 2 about FSH.
SwimScore uses CLIA-certified labs for all semen analysis and hormone testing, assessed against WHO 6th Edition clinical thresholds.
